SG11201810254UA - Blood sample analysis method and system, for determining diabetes - Google Patents

Blood sample analysis method and system, for determining diabetes

Info

Publication number
SG11201810254UA
SG11201810254UA SG11201810254UA SG11201810254UA SG11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA
Authority
SG
Singapore
Prior art keywords
blood sample
sample analysis
analysis method
diabetes
diabetes complications
Prior art date
Application number
SG11201810254UA
Other languages
English (en)
Inventor
Yoshitaka Isaka
Tomonori Kimura
Keiko Yasuda
Kenji Hamase
Masashi Mita
Original Assignee
Univ Osaka
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka, Shiseido Co Ltd filed Critical Univ Osaka
Publication of SG11201810254UA publication Critical patent/SG11201810254UA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7042—Aging, e.g. cellular aging

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201810254UA 2016-05-17 2017-05-17 Blood sample analysis method and system, for determining diabetes SG11201810254UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016099163 2016-05-17
PCT/JP2017/018592 WO2017200025A1 (ja) 2016-05-17 2017-05-17 糖尿病を判定するための血液試料の分析方法及びシステム

Publications (1)

Publication Number Publication Date
SG11201810254UA true SG11201810254UA (en) 2018-12-28

Family

ID=60326004

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810254UA SG11201810254UA (en) 2016-05-17 2017-05-17 Blood sample analysis method and system, for determining diabetes

Country Status (8)

Country Link
US (1) US20190271708A1 (ja)
EP (1) EP3460478A4 (ja)
JP (2) JP6609282B2 (ja)
CN (1) CN109154619A (ja)
AU (1) AU2017266331A1 (ja)
IL (1) IL263024A (ja)
SG (1) SG11201810254UA (ja)
WO (1) WO2017200025A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019235591A1 (ja) * 2018-06-07 2019-12-12 国立大学法人金沢大学 腎臓病の病態バイオマーカー
CN113196063A (zh) * 2018-10-17 2021-07-30 镜株式会社 用于判定危险期的肾损伤的标志物
JPWO2020196437A1 (ja) * 2019-03-22 2020-10-01
JPWO2020196436A1 (ja) * 2019-03-22 2020-10-01
CN114113349B (zh) * 2020-08-26 2024-01-23 湖南农业大学 一种基于二维液相色谱-紫外衍生法同时测定生物基质中5种氨基酸类神经递质的方法
WO2022244842A1 (ja) * 2021-05-19 2022-11-24 Kagami株式会社 糖質代謝の調整のための組成物及び、対象の糖質代謝の状態を評価する方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
EP1837657A1 (en) * 2006-03-24 2007-09-26 Metanomics GmbH Means and method for predicting or diagnosing diabetes
CA2647122A1 (en) * 2006-03-24 2007-10-04 Metanomics Gmbh Means and method for diagnosing diabetes
US20080026378A1 (en) * 2006-07-28 2008-01-31 Gian Franco Bottazzo Prediction and prophylactic treatment of type 1 diabetes
WO2008156617A2 (en) * 2007-06-15 2008-12-24 Smithkline Beecham Corporation Methods and kits for predicting treatment response in type ii diabetes mellitus patients
CN101796408B (zh) * 2007-06-29 2014-05-07 奎斯特诊断投资公司 用液相层析-质谱法分析体液内的氨基酸
JP5497770B2 (ja) * 2009-09-16 2014-05-21 旭化成ファーマ株式会社 急性期脳梗塞におけるアテローム血栓性脳梗塞の病型鑑別方法および発症予測方法
JP2011092100A (ja) * 2009-10-29 2011-05-12 Dna Chip Research Inc 生理的状態変化と生理的状態に変化を与える要因の効果を評価する遺伝子マーカー、評価方法、評価システム、及びコンピュータプログラム
WO2012164525A2 (en) * 2011-06-01 2012-12-06 Ecole Polytechnique Federale De Lausanne (Epfl) Aging biomarkers
CN110133301B (zh) * 2012-03-18 2022-03-22 镜株式会社 疾病样品分析装置、分析***及分析方法
US20150260704A1 (en) * 2012-07-30 2015-09-17 In Ovo B.V. Gender, viability and/or developmental stage determination of avian embryos in ovo
CN102901789A (zh) * 2012-09-21 2013-01-30 中国药科大学 糖尿病肾病早期诊断的血清代谢标志物测定方法
EP2951313B1 (en) * 2013-01-31 2018-03-07 Metabolon, Inc. Biomarkers related to insulin resistance progression and methods using the same
EP3081939B1 (en) * 2013-12-11 2021-02-17 Kagami Inc. Marker for early diagnosis of kidney failure
JP2017516085A (ja) * 2014-04-08 2017-06-15 メタボルン インコーポレーティッド 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法

Also Published As

Publication number Publication date
JP6609282B2 (ja) 2019-11-20
AU2017266331A1 (en) 2018-12-06
EP3460478A1 (en) 2019-03-27
JP2019191192A (ja) 2019-10-31
JP2017207490A (ja) 2017-11-24
IL263024A (en) 2018-12-31
AU2017266331A8 (en) 2018-12-20
CN109154619A (zh) 2019-01-04
WO2017200025A1 (ja) 2017-11-23
EP3460478A4 (en) 2020-01-08
US20190271708A1 (en) 2019-09-05
JP6884346B2 (ja) 2021-06-09

Similar Documents

Publication Publication Date Title
SG11201810254UA (en) Blood sample analysis method and system, for determining diabetes
EA201891293A1 (ru) Мультиспецифические антитела
BR112017004379A2 (pt) determinação de vivacidade em multi-estágio
EA201891292A1 (ru) Мультиспецифические антитела
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
MX2019003473A (es) Metodos mejorados para evaluar el estado de ubiquitin carboxi-terminal hidrolasa l1 (uch-l1) en muestras de pacientes.
EP3816303A3 (en) Breast cancer detection kit or device, and method for detecting breast cancer
WO2016130704A3 (en) Methods and compositions for analyzing cellular components
BR112014016313A2 (pt) medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
BR112017018821A2 (pt) métodos para quantificação de níveis de insulina através de espectrometria de massa
PH12019502558A1 (en) Diagnostic assays for detecting, quantifying, and/or tracking microbes and other analytes
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
MX364886B (es) Lente oftálmica con sistema microfluídico.
EP4365602A3 (en) Stomach cancer biomarker and detection method
EA201001867A1 (ru) Зажим, предназначенный для захватывания держателя биологических проб, комплект компонентов, состоящий из держателя биологических проб и соответствующего зажима, и устройство для обработки и/или анализа
ATE554389T1 (de) Apex als marker für lungenkrebs
SG11201810261UA (en) Kidney disease prognosis prediction method and system
EP4328587A3 (en) Use of a kit or device and method for detecting dementia
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
MX2018006189A (es) Lactoferrina para uso en el diagnostico o el pronostico de la enfermedad de alzheimer o en el diagnostico de la enfermedad de parkinson.
BR112022008217A2 (pt) Métodos e dispositivos para sequenciamento
MX2021004894A (es) Analisis de beta-caseina de leche y productos lacteos.